Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Lower inflation primes Canada's real estate market for a shift

June’s inflation rate reduced to 2.7 percent from 2.9 percent in May, giving the BOC a reason to lower the current policy interest rate. On June 5 the Bank of Canada lowered the interest rate 25 basis points to 4.75 per cent, and experts are betting on ano...

Buzz on the Bullboards: Whose stocks sizzle during summer holidays?

As we get through the summer holiday season, the typically calmer market environment presents a prime opportunity for investors to evaluate their portfolios and consider new investments. The TSX continues to offer a variety of promising stocks, particularly in energ...

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...

Gold opportunity in Australia’s Northern Territory shines bright

The following is a transcription of the above video, and The Market Online has edited it for clarity . The Market Online recently caught up with Vista Gold Corp. (TSXV:VGZ) President & CEO Fred Earnest. Vista Gold Corp. is a gold project developer with its fl...

BioNTech & Cardiol Therapeutics – on the verge of a breakout

Compared with the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition t...

Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus

The biotech sector has significantly lagged behind the performance of artificial intelligence and high-tech this year. This is because of high inflation, which in turn has made an imminent interest rate cut unlikely. Nevertheless, Germany’s economic condit...

Is China getting serious? Rheinmetall and Almonty Industries profit

Is China really preparing for an attack on Taiwan? It is well known that China is massively increasing its gold reserves. But why tungsten, too? After all, China itself is the largest producer of this raw material, which is not only in demand in the arms industry. ...

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Last week saw the Canadian and U.S. stock markets grappling with a host of challenges, from surging inflation data to escalating tensions in the Middle East. Adding to the mix, a historic trial commenced in New York, as former U.S. President Donald Trump faced allegations...

U.S. spot Bitcoin ETFs are live – what happens to Canada’s crypto ETFs?

By Shaed Hashimkhial The SEC’s endorsement of U.S. spot Bitcoin ETFs significantly influenced the cryptocurrency markets. Shortly after the announcement, we witnessed a substantial rally in Bitcoin, a notable increase in Ethereum’s...

Buzz on the Bullboards: Bombardier, Baytex and Tilray turn heads

North American stocks have had a strong week. Markets on both sides of the border responded well to the U.S. Federal Reserve’s vote to hold interest rates between 5.25 per cent and 5.50 per cent for a fifth straight meeting. The central bank has kept r...
1 2 3 4 5 6 7 8 9 10 ...